Source: Annual Congress 2005 - Clinical and experimental studies in lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
I. A. Forrest, S. Scorfield, D. M. Murphy, P. Botha, J. H. Dark, C. Ward, P. A. Corris, P. G. Middleton (Newcastle-upon-Tyne, United Kingdom). TNFα-308 polymorphism associates with acute lung allograft rejection. Eur Respir J 2005; 26: Suppl. 49, 1137

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 A model of chronic lung allograft rejection in the rat Source: Eur Respir J 2010; 35: 1354-1363 Year: 2010 Mechanistical differences of chronic lung allograft dysfunction phenotypes in lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Breath VOC patterns of lung transplant recipients with and without chronic lung allograft dysfunction (CLAD) Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Rapamycin in patients with chronic lung rejection Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Lung volumes predict survival in patients with chronic lung allograft dysfunction Source: Eur Respir J , 49 (4)  1601315; DOI: 10.1183/13993003.01315-2016 Year: 2017 Oxygenated hemoglobin predicts outcome in patients with chronic lung allograft dysfunction Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward? Year: 2021 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Exploring the BAL profile in acute rejection and lymphocytic bronchiolitis after lung transplantation Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options Year: 2009 Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival Source: Eur Respir J, 56 (3) 1902292; 10.1183/13993003.02292-2019 Year: 2020 KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Hyperinflation correlates with poor exercise tolerance in recipients with advanced chronic lung allograft dysfunction Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003 Differential gene expression of aquaporins (AQP) in lung transplant recipients with acute lung rejection. Source: International Congress 2018 – Moving lung transplantation forward Year: 2018